Organisation · founded 2002
Centre for the AIDS Programme of Research in South Africa
Durban, South Africa · caprisa.org/Default
- Citations, last 5 years
- 18.3k
- Works, last 5 years
- 952
- h-index
- 233
- Scientists listed
- 0
- Grants since 2016
- 71
Grants received
2025–2029 · research · NIHR Global Health Research
Leveraging the law for effective pandemic preparedness: lessons from the Covid-19 response in South Africa
Centre for the AIDS Programme of Research in South Africa · funded by Department of Health and Social Care
2025–2028 · research · Global Health
CAPRISA - to support development of a microbial-based therapeutic that promotes stable Lactobacillus-dominant microbiomes linked to lower rates of HIV acquis...
Centre for the AIDS Programme of Research in South Africa · funded by Bill and Melinda Gates Foundation
2025–2030 · research · Global Health
CAPRISA - to establish a Microbiome Research Support in KwaZulu-Natal.
Centre for the AIDS Programme of Research in South Africa · funded by Bill and Melinda Gates Foundation
2024–2027 · cooperative agreement · UM1
KwaZulu-Natal Clinical Trials Unit - Supplemental infrastructure request 2024
Quarraisha Abdool Karim · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2024–2027 · research · Global Health
CAPRISA - to produce research assessing the effects of prior policy changes, state of pediatric HIV treatment, and the effectiveness of private sector HIV care.
Centre for the AIDS Programme of Research in South Africa · funded by Bill and Melinda Gates Foundation
2024–2027 · cooperative agreement · UM1
KwaZulu-Natal Clinical Trials Unit
Quarraisha Abdool Karim · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2023–2027 · cooperative agreement · UG1
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
Nivashnee Naicker · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2023–2027 · cooperative agreement · UG1
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
Nivashnee Naicker · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2023–2027 · cooperative agreement · UG1
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
Nivashnee Naicker · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2022–2025 · research · Global Health
CAPRISA - to evaluate key policy changes and implementation challenges in the South African HIV & TB programme
Centre for the AIDS Programme of Research in South Africa · funded by Bill and Melinda Gates Foundation
2022–2026 · research · Global Health
CAPRISA - to understand recovery of the vaginal microbiome after childbirth in South African women.
Centre for the AIDS Programme of Research in South Africa · funded by Bill and Melinda Gates Foundation
2022–2025 · research · Global Health
CAPRISA - to conduct a First in Human clinical trial of a live biotherapeutic intervention for vaginal dysbiosis and reduction of bacterial vaginosis
Centre for the AIDS Programme of Research in South Africa · funded by Bill and Melinda Gates Foundation
2021–2026 · research · Global Health
CAPRISA - to determine if Lactobacilli can be recovered from a BV patient cohort and to study the characteristics of the recovered Lactobacilli.
Centre for the AIDS Programme of Research in South Africa · funded by Bill and Melinda Gates Foundation
2021–2026 · research · R01
Mechanisms of type I IFN signaling and HIV risk in the female genital tract
Aida Sivro · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2021–2025 · research · RIA
Triage Test for All Oral DR TB Regimen: T2RiAD study
Kogieleum Naidoo · Centre for the AIDS Programme of Research in South Africa · funded by European and Developing Countries Clinical Trials Partnership
2021–2026 · research · R01
Mechanisms of type I IFN signaling and HIV risk in the female genital tract
Aida Sivro · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2021–2026 · research · R01
Mechanisms of type I IFN signaling and HIV risk in the female genital tract
Aida Sivro · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2021–2026 · research · R01
Mechanisms of type I IFN signaling and HIV risk in the female genital tract
Aida Sivro · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2021–2026 · research · R01
Mechanisms of type I IFN signaling and HIV risk in the female genital tract
Aida Sivro · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2025 · research · R01
Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa
Kelly E. Dooley · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2025 · research · R01
Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa
Kelly E. Dooley · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2025 · research · R01
Combination biomarkers for preventing HIV and adverse birth outcomes in a South African pregnancy cohort: implications for infant health
Heather Beryl Jaspan · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2025 · research · R01
Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa
Kelly E. Dooley · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2025 · research · R01
Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa
Kelly E. Dooley · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2022 · research · RIA
Natural History and Laboratory Tests for COVID-19 in South Africa
Ayesha Kharsany · Centre for the AIDS Programme of Research in South Africa · funded by European and Developing Countries Clinical Trials Partnership
2020–2025 · research · R01
Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa
Kelly E. Dooley · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2022 · research · Global Health
CAPRISA - to create a platform for adaptive clinical trials of interventions for vaginal dysbiosis and plan future studies
Centre for the AIDS Programme of Research in South Africa · funded by Bill and Melinda Gates Foundation
2020–2025 · fellowship · TMA
The Individualized Multi-/Extensively Drug-Resistant Tuberculosis Treatment Strategy Study
Nesri Padayatchi · Centre for the AIDS Programme of Research in South Africa · funded by European and Developing Countries Clinical Trials Partnership
2020–2025 · research · R01
Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa
Kelly E. Dooley · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2025 · research · R01
Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa
Kelly E. Dooley · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2025 · research · R01
Combination biomarkers for preventing HIV and adverse birth outcomes in a South African pregnancy cohort: implications for infant health
Heather Beryl Jaspan · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2025 · research · R01
Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa
Kelly E. Dooley · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2025 · research · R01
Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa
Kelly E. Dooley · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2023 · fellowship · TMA
Monitoring of HIV drug resistance in South Africa and innovative approaches to HIV drug resistance testing
Benjamin Chimukangara · Centre for the AIDS Programme of Research in South Africa · funded by European and Developing Countries Clinical Trials Partnership
2020–2025 · research · R01
Combination biomarkers for preventing HIV and adverse birth outcomes in a South African pregnancy cohort: implications for infant health
Heather Beryl Jaspan · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2023 · fellowship · TMA
Evaluating the Impact of Metformin on Mycobacterium tuberculosis Growth in Macrophages
Nikita Naicker · Centre for the AIDS Programme of Research in South Africa · funded by European and Developing Countries Clinical Trials Partnership
2020–2025 · research · R01
Combination biomarkers for preventing HIV and adverse birth outcomes in a South African pregnancy cohort: implications for infant health
Heather Beryl Jaspan · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2025 · research · R01
Combination biomarkers for preventing HIV and adverse birth outcomes in a South African pregnancy cohort: implications for infant health
Heather Beryl Jaspan · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2020–2025 · research · R01
Second Generation InSTIs for the Treatment of HIV-1 in patients with TB co-infection on Rifampicin-based Treatment in KwaZulu Natal, South Africa
Kelly E. Dooley · Centre for the AIDS Programme of Research in South Africa · funded by National Institutes of Health
2019–2024 · fellowship · TMA
Effect of Pre-Exposure Prophylaxis (PrEP) on immune responses systemically and mucosally in healthy individuals in the CAPRISA 082 study- (PrEP Underlying Mucosal-immunity Before/After PUMBA)
Derseree Archary · Centre for the AIDS Programme of Research in South Africa · funded by European and Developing Countries Clinical Trials Partnership